The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
11-methoxy-3,9-dimethyl-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide ID: ALA273149
PubChem CID: 16759937
Max Phase: Preclinical
Molecular Formula: C18H16N2O3S
Molecular Weight: 340.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc2ccc(C)nc2c2c1-c1cc(C)ccc1S(=O)(=O)N2
Standard InChI: InChI=1S/C18H16N2O3S/c1-10-4-7-15-13(8-10)16-14(23-3)9-12-6-5-11(2)19-17(12)18(16)20-24(15,21)22/h4-9,20H,1-3H3
Standard InChI Key: UXHUBTDSTIIYHF-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
-4.6339 -18.3161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6339 -19.1433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9215 -19.5546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9215 -17.9002 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.2045 -18.3161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2081 -19.1433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4975 -19.5575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7787 -19.1493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4904 -17.9033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7778 -18.3236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7643 -16.6718 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-2.4868 -17.0783 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0516 -17.0921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0647 -17.9185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3596 -18.3407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3633 -17.9412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3764 -17.1148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3333 -16.6879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0684 -18.3648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3619 -15.9580 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.1844 -15.9580 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.3472 -17.9066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0680 -19.5636 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.0714 -20.3860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9 12 1 0
10 14 1 0
13 11 1 0
11 12 1 0
13 14 1 0
1 2 1 0
1 4 2 0
2 3 2 0
5 9 2 0
6 7 2 0
7 8 1 0
13 18 2 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
8 10 2 0
16 19 1 0
9 10 1 0
11 20 2 0
3 6 1 0
11 21 2 0
5 4 1 0
1 22 1 0
5 6 1 0
8 23 1 0
23 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 340.40Molecular Weight (Monoisotopic): 340.0882AlogP: 3.64#Rotatable Bonds: 1Polar Surface Area: 68.29Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 6.51CX Basic pKa: 4.20CX LogP: 2.78CX LogD: 2.11Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.73Np Likeness Score: -0.70
References 1. Xie Y, Deng S, Thomas CJ, Liu Y, Zhang YQ, Rinderspacher A, Huang W, Gong G, Wyler M, Cayanis E, Aulner N, Többen U, Chung C, Pampou S, Southall N, Vidović D, Schürer S, Branden L, Davis RE, Staudt LM, Inglese J, Austin CP, Landry DW, Smith DH, Auld DS.. (2008) Identification of N-(quinolin-8-yl)benzenesulfonamides as agents capable of down-regulating NFkappaB activity within two separate high-throughput screens of NFkappaB activation., 18 (1): [PMID:18024113 ] [10.1016/j.bmcl.2007.10.100 ] 2. Tsai KC, Teng LW, Shao YM, Chen YC, Lee YC, Li M, Hsiao NW.. (2009) The first pharmacophore model for potent NF-kappaB inhibitors., 19 (19): [PMID:19726185 ] [10.1016/j.bmcl.2009.08.021 ]